MOST POWERFUL OBESITY DRUG YET: PEOPLE LOST UP TO 25% OF WEIGHT IN TRIAL

Summary from the TLDR newsletter

Late-stage clinical trial data on the obesity drug retatrutide showed an average loss of 25% of body weight after 90 weeks. More than a third of the participants taking the drug in the trial lost 30% or more of their weight. The drug also helped reduce knee pain and sleep apnea events, and it improved cardiometabolic measurements across the board. At the start of the trial, more than a third of trial participants had prediabetes - the condition had resolved in more than 90% of those participants by the end.